International Consolidated Companies, Inc. (INCC)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
International Consolidated Companies, Inc. (INCC) with AI Score 59/100 (Hold). International Consolidated Companies, Inc. (INCC) develops and markets CBD products specifically for the pet and animal markets. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 16, 2026International Consolidated Companies, Inc. (INCC) Industrial Operations Profile
International Consolidated Companies, Inc. specializes in developing and marketing CBD products for pets and animals, positioning itself in a growing niche within the specialty business services sector with a focus on innovative health solutions.
Investment Thesis
International Consolidated Companies, Inc. operates in a rapidly growing market for CBD products tailored for pets, which is expected to expand significantly over the next few years. The company boasts a remarkable gross margin of 100%, indicative of its pricing power and efficient cost structure. With the increasing legalization and acceptance of CBD across various markets, INCC stands to benefit from a broader consumer base. Key growth catalysts include the rising trend of pet humanization, where owners are increasingly seeking premium health products for their pets. Furthermore, the company's lean operational model allows for flexibility and responsiveness to market changes. However, potential risks include regulatory uncertainties surrounding CBD products and competition from other established players in the industry. Investors should monitor these dynamics closely as they assess INCC's future performance.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap: $0.00B, indicating a need for growth and increased market interest.
- Gross Margin: 100.0%, showcasing exceptional pricing power and cost efficiency.
- Debt-to-Equity Ratio: 722.22, highlighting a significant reliance on debt financing.
- Beta: 0.72, suggesting lower volatility compared to the broader market.
- No Dividend Yield, reflecting a focus on reinvestment rather than returning capital to shareholders.
Competitors & Peers
Strengths
- Exceptional gross margin of 100%, indicating strong pricing power.
- Focused product line catering specifically to the pet market.
- Agile operational structure with a small, dedicated team.
Weaknesses
- Limited employee base may restrict growth and scalability.
- High debt-to-equity ratio suggests reliance on debt financing.
- Lack of established brand recognition compared to larger competitors.
Catalysts
- Upcoming: Expansion of product offerings to capture a larger market share.
- Ongoing: Increasing consumer demand for CBD products for pets.
- Upcoming: Potential partnerships with retailers and veterinarians to enhance market presence.
- Ongoing: Regulatory developments favoring the legalization of CBD products.
- Upcoming: Marketing campaigns aimed at raising brand awareness.
Risks
- Potential: Regulatory changes that could impact the sale of CBD products.
- Ongoing: Intense competition in the CBD pet product market.
- Potential: Economic downturns affecting consumer spending on premium pet products.
- Ongoing: Limited financial resources may restrict growth initiatives.
Growth Opportunities
- Growth opportunity 1: The pet CBD market is projected to reach $1.7 billion by 2025, driven by increasing consumer awareness and demand for natural health products. INCC can leverage this trend by expanding its product offerings and enhancing its marketing strategies to reach a broader audience.
- Growth opportunity 2: The legalization of hemp-derived CBD products in various states is opening new avenues for market expansion. INCC can capitalize on this regulatory shift by increasing distribution channels and partnerships with retailers focused on pet health products.
- Growth opportunity 3: The rise of e-commerce presents a significant opportunity for INCC to enhance its sales channels. By investing in online marketing and direct-to-consumer sales strategies, the company can tap into a growing segment of pet owners who prefer purchasing health products online.
- Growth opportunity 4: Collaborations with veterinarians and pet health professionals can enhance credibility and drive product adoption. By establishing partnerships that promote the benefits of CBD for pets, INCC can increase brand visibility and trust among consumers.
- Growth opportunity 5: Expanding into international markets where CBD products are gaining acceptance can provide a substantial growth avenue. INCC can explore global opportunities, particularly in regions with increasing pet ownership and demand for health products.
Opportunities
- Growing market for CBD pet products with significant revenue potential.
- Increasing acceptance of CBD products among consumers.
- Potential for international market expansion as regulations evolve.
Threats
- Regulatory uncertainties surrounding CBD products.
- Intense competition from established and emerging players.
- Market volatility and changing consumer preferences.
Competitive Advantages
- Strong focus on product quality and innovation in the CBD space.
- Lean operational model allows for quick adaptation to market changes.
- Established brand reputation in a niche market of pet health products.
- Growing consumer awareness and acceptance of CBD for pets enhances market position.
About INCC
International Consolidated Companies, Inc. was founded in 2002 and is headquartered in Sarasota, Florida. Originally named Sign Media Systems, Inc., the company rebranded in September 2007 to reflect its focus on the burgeoning CBD market, particularly for pets and animals. Over the years, INCC has dedicated itself to developing high-quality CBD products aimed at improving the health and well-being of pets. The company operates with a lean structure, employing only three individuals, which allows for agile decision-making and a focused approach to product development and marketing. The CBD market for pets is experiencing rapid growth, driven by increasing consumer awareness of the benefits of CBD, leading to a surge in demand for these products. INCC's commitment to quality and innovation positions it favorably in this competitive landscape, where it aims to carve out a significant market share. As the pet wellness industry continues to expand, INCC is well-placed to leverage its expertise in CBD formulations to meet the evolving needs of pet owners.
What They Do
- Develops CBD products specifically for the pet and animal markets.
- Markets high-quality, innovative health solutions for pets.
- Focuses on improving the health and well-being of animals through natural products.
- Operates with a lean team to ensure agility and responsiveness to market trends.
- Engages in research and development to enhance product offerings.
- Aims to carve out a significant market share in the growing CBD pet product sector.
Business Model
- Generates revenue through the sale of CBD products for pets.
- Focuses on high-margin products to maximize profitability.
- Utilizes direct-to-consumer and retail channels for distribution.
- Invests in marketing and product development to drive sales.
- Maintains a lean operational structure to control costs.
Industry Context
The specialty business services industry, particularly in the CBD sector for pets, is witnessing robust growth, driven by increasing consumer demand for natural health products. The market for CBD pet products is projected to grow significantly, as pet owners increasingly seek alternative health solutions for their animals. Competition is intensifying, with various players entering the market, but INCC's focus on quality and innovation positions it well. As the overall pet care market continues to expand, driven by trends such as pet humanization, companies like INCC are poised to capitalize on these shifts.
Key Customers
- Pet owners seeking natural health solutions for their animals.
- Retailers specializing in pet health and wellness products.
- Veterinarians and pet health professionals recommending CBD products.
- Online consumers purchasing pet wellness products through e-commerce platforms.
Financials
Chart & Info
International Consolidated Companies, Inc. (INCC) stock price: Price data unavailable
Latest News
No recent news available for INCC.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for INCC.
Price Targets
Wall Street price target analysis for INCC.
MoonshotScore
What does this score mean?
The MoonshotScore rates INCC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Specialty Business ServicesLeadership: Antonio F. Uccello
CEO
Antonio F. Uccello has been at the helm of International Consolidated Companies, Inc. since its inception in 2002. With a background in business management and a keen interest in health products, he has guided the company through its evolution from Sign Media Systems, Inc. to its current focus on CBD for pets. His leadership has been instrumental in establishing the company's niche in the competitive pet health market.
Track Record: Under Antonio's leadership, INCC has successfully transitioned into the CBD market, achieving a gross margin of 100%. His strategic decisions have positioned the company to capitalize on the growing demand for pet wellness products.
INCC OTC Market Information
The OTC Other tier includes stocks that do not meet the higher listing requirements of major exchanges like NYSE or NASDAQ. These stocks may have less stringent reporting standards, which can result in less transparency for investors. However, they also offer opportunities for investment in smaller or emerging companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited regulatory oversight compared to stocks listed on major exchanges.
- Potential for lower liquidity, making it challenging to buy or sell shares.
- Increased volatility associated with smaller companies in the OTC market.
- Verify the company's financial statements and disclosures.
- Assess the competitive landscape within the CBD pet product market.
- Research regulatory developments affecting CBD products.
- Evaluate the company's growth strategy and market positioning.
- Investigate management's track record and industry experience.
- Established history since 2002, indicating experience in the market.
- Transition to a focused product line in a growing industry.
- Presence in the CBD market, which is gaining consumer acceptance.
International Consolidated Companies, Inc. Stock: Key Questions Answered
What does International Consolidated Companies, Inc. do?
International Consolidated Companies, Inc. specializes in developing and marketing CBD products for the pet and animal markets. The company focuses on creating high-quality health solutions that cater to the growing demand among pet owners for natural alternatives to traditional pet health products.
How does International Consolidated Companies, Inc. compare to competitors in its industry?
International Consolidated Companies, Inc. operates in a competitive landscape alongside companies like AACS and ECOX, which also focus on pet health products. INCC differentiates itself through its exclusive focus on CBD products, aiming to carve out a niche in the rapidly growing market for pet wellness solutions.
What are the key financial metrics investors watch for INCC?
Key financial metrics for International Consolidated Companies, Inc. include its gross margin of 100%, which exceeds industry averages, and its debt-to-equity ratio of 722.22, indicating a high reliance on debt. Investors should also monitor market capitalization and revenue growth as indicators of the company's financial health and market position.
What are the main risks for INCC?
Main risks for International Consolidated Companies, Inc. include regulatory uncertainties regarding CBD products, which could impact sales and operations. Additionally, the company faces ongoing competition from established players in the CBD pet market and potential economic downturns that may affect consumer spending on premium pet health products.
What are the key factors to evaluate for INCC?
International Consolidated Companies, Inc. (INCC) currently holds an AI score of 59/100, indicating moderate score. Key strength: Exceptional gross margin of 100%, indicating strong pricing power.. Primary risk to monitor: Potential: Regulatory changes that could impact the sale of CBD products.. This is not financial advice.
How frequently does INCC data refresh on this page?
INCC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven INCC's recent stock price performance?
Recent price movement in International Consolidated Companies, Inc. (INCC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Exceptional gross margin of 100%, indicating strong pricing power.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider INCC overvalued or undervalued right now?
Determining whether International Consolidated Companies, Inc. (INCC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on available information as of March 2026; some financial metrics may not be fully disclosed.